Why Are Carbohydrate Chains Important in the Liver?
Carbohydrate chains, or glycans, are complex biomolecules composed of linked monosaccharides that form linear or branched structures. These carbohydrate chains in glycobiology are ubiquitously present on cell surfaces and secreted proteins, playing pivotal roles in cellular communication, molecular recognition, and homeostasis. In the liver—the metabolic hub of vertebrates—glycans in liver function are indispensable for regulating processes ranging from nutrient metabolism to toxin clearance.
The liver synthesizes, modifies, and degrades carbohydrate chains through enzymatic cascades that dictate their structural diversity. For instance, glycosylation in liver cells ensures proper folding and trafficking of hepatic proteins, while hepatic carbohydrate metabolism governs energy distribution to peripheral tissues. Disruptions in these processes correlate with pathologies such as non-alcoholic fatty liver disease (NAFLD) and cirrhosis. To decode these mechanisms, Creative Biolabs offers liver glycomics profiling services, leveraging advanced technologies to analyze glycan structures and their functional implications in hepatic health and disease.
Fig.1 Schematic diagram of liver cancer progression and associated N-glycan type changes.1,3
Glycosylation in Liver Cells
Glycosylation—the enzymatic attachment of sugars to proteins or lipids—occurs predominantly in the endoplasmic reticulum (ER) and Golgi apparatus. This post-translational modification generates diverse carbohydrate chains that modulate protein stability, ligand-receptor interactions, and intracellular signaling. In hepatocytes, glycosylation ensures the functional integrity of enzymes like cytochrome P450 (CYP450) and UDP-glucuronosyltransferases (UGTs), which are critical for detoxification. Glycosylation in liver cells directly impacts protein localization and activity. For example, asialoglycoprotein receptors on hepatocytes recognize terminal galactose residues on glycoproteins, facilitating their endocytosis and degradation. Aberrant glycosylation disrupts this process, leading to toxic protein accumulation.
The role of glycosylation in liver detoxification processes is exemplified by phase II metabolism, where UGTs conjugate glucuronic acid (a sugar derivative) to xenobiotics, enhancing their solubility for biliary excretion. Glycosylated transporters like multidrug resistance protein 2 (MRP2) further shuttle these conjugates into bile. To model these pathways, Creative Biolabs developed the glycosylation site mapping service, identifying specific glycosylation sites that influence the detoxification process.
Hepatic Carbohydrate Metabolism
The liver orchestrates hepatic carbohydrate metabolism via three primary pathways:
-
Glycolysis: Converts glucose to pyruvate, yielding ATP and NADH.
-
Glycogenesis: Synthesizes glycogen—a complex animal carbohydrate made of linked chains of glucose molecules—for short-term energy storage.
-
Gluconeogenesis: Generates glucose from non-carbohydrate precursors during fasting.
Excess glucose not stored as glycogen is funneled into de novo lipogenesis (DNL), forming long-chain triglycerides (LCTs)—not medium-chain triglycerides (MCTs), which are primarily diet-derived. LCTs dominate hepatic lipid pools in overnutrition states.
Normal vs. Abnormal Hepatic Carbohydrate Metabolism
Balanced liver carbohydrate metabolism and its implications for health are evident in insulin signaling. Postprandial insulin suppresses gluconeogenesis, directing glucose into glycogen. Chronic insulin resistance, however, blunts this response, causing hyperglycemia and compensatory DNL—a hallmark of NAFLD. Studies show that glycan modification in hepatic cells during metabolic regulation influences insulin receptor activity; sialylation of its α-subunit enhances ligand binding, while aberrant branching reduces sensitivity. Disruption of glucose metabolism is closely associated with fatty liver and type 2 diabetes. There was a study showing that insulin resistance in hepatocytes leads to excessive gluconeogenesis and results in fasting hyperglycemia, with finding shown that mice with a Cx32 gene defect exhibit hypoglycemia and liver enlargement due to abnormal glycogenolysis. There are several metabolic pathways influenced by glycosylation:
|
Metabolic Pathway
|
Influence of Glycosylation
|
|
Pentose Phosphate Pathway (PPP)
|
Supplies NADPH for detoxification and nucleotide synthesis. N-glycans on glucose-6-phosphate dehydrogenase (G6PD) regulate its activity.
|
|
Oxidative Phosphorylation
|
Indirect influence via carbohydrate metabolism. The oxidative phosphorylation with the electron transport chain relies on glycolytic NADH shuttling into mitochondria.
|
|
Glycolysis
|
Glycosylation influences the activity of key glycolytic enzymes, such as hexokinase and pyruvate kinase, affecting the flux through glycolysis.
|
|
Citric Acid Cycle (TCA Cycle)
|
Glycosylation can modulate enzymes like citrate synthase and isocitrate dehydrogenase, influencing the rate of the TCA cycle and energy production.
|
Clinical Implications of Glycan Dysregulation
In hepatocellular carcinoma (HCC), truncated O-glycans (e.g., Tn antigen) promote metastasis by disrupting cell adhesion. Conversely, terminal sialylation on acute-phase proteins like α1-antitrypsin exacerbates inflammation in cirrhosis. Creative Biolabs' glycan-based diagnostic development identifies such glyco-biomarkers for early disease detection. GalNAc-siRNA conjugates exploit hepatocyte-specific asialoglycoprotein receptors for targeted gene silencing—a paradigm of glycosylation in liver cells harnessed for drug delivery. Similarly, inhibiting fucosylation enzymes (e.g., FUT8) curtails HCC progression in preclinical models. It's clear that glycans play a pivotal role in liver diseases such as hepatocellular carcinoma (HCC) and cirrhosis. At Creative Biolabs, we are committed to supporting your research with our cutting-edge services tailored to uncover the complexities of glycosylation and its impact on liver function and disease progression. To help you explore the fascinating world of glycans and their role in liver health, we offer a variety of specialized services designed to provide you with the insights you need:
|
Service
|
Service Description
|
|
Liver Glycan Profiling
|
Analyzes glycan structures and their functional implications in hepatic health and disease.
|
|
High-throughput Glycan Screening
|
A comprehensive service that allows researchers to screen and analyze a large number of glycan samples efficiently.
|
|
Glycosylation Site Mapping
|
Focuses on identifying glycosylation sites that modulate liver enzymes for efficient detoxification.
|
|
Glycan Sequencing and Profiling
|
Analyzes the exact sequence of glycans, providing insight into their functional roles in various diseases.
|
|
Glycoprotein Analysis Services
|
Provides a comprehensive analysis of glycoproteins, including structure, quantification, and functional profiling.
|
|
Glycosylation in Drug Development
|
Offers glycoengineering services to enhance the therapeutic properties of drugs through optimized glycosylation patterns.
|
References
-
Hu, Mengyu, et al. "The role of N-glycosylation modification in the pathogenesis of liver cancer." Cell Death & Disease 14.3 (2023): 222. https://doi.org/10.1038/s41419-023-05733-z
-
Jarrar, Yazun, and Su-Jun Lee. "The functionality of UDP-glucuronosyltransferase genetic variants and their association with drug responses and human diseases." Journal of Personalized Medicine 11.6 (2021): 554. https://doi.org/10.3390/jpm11060554
-
Distributed under Open Access license CC BY 4.0, without modification.
Related Services
Resources
For Research Use Only.
Contact Us
Follow us on
